Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

GSMA's Global Mobile Awards To Recognise Mobile Innovation in the mHealth Sector

September 23, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

LONDON, Sept. 23 /- The GSMA, which represents the interests of the worldwide mobile communications industry, has launched its prestigious 16th Annual Global Mobile Awards programme. New categories have been added to recognise excellence, achievement and innovation in the broad and...

TOPICS:

Ultrasonix Announces New Digital Ultrasound Exam Recording Technology

September 23, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

RICHMOND, British Columbia, Sept. 23 /- Ultrasonix Medical Corporation, a leading developer and manufacturer of high quality diagnostic ultrasound imaging systems is pleased to announce today the introduction of SonixVCR, a software-based innovation that records, stores, and exports...

TOPICS:

DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials

September 23, 2010 1:33 am | by Bio-Medicine.Org | News | Comments

WILMINGTON, Del., and HEERLEN, Netherlands, Sept. 23 /- DuPont (NYSE: DD ) and Royal DSM N.V. announce an agreement to form a joint venture to develop, manufacture and commercialize advanced surgical biomedical materials, pending European Union regulatory approval. The joint venture will...

TOPICS:
Advertisement

US and EU Regulatory Submissions for Vandetanib in Advanced Medullary Thyroid Cancer Accepted for Review

September 23, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

LONDON, Sept. 23 /- AstraZeneca today announced that the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of patients with advanced medullary thyroid cancer...

TOPICS:

New TB vaccine enters clinical testing

September 22, 2010 11:34 pm | by EurekAlert | News | Comments

(Aeras Global TB Vaccine Foundation) Aeras announced it will initiate a Phase I clinical trial of an investigational live recombinant tuberculosis vaccine at Saint Louis University. The new vaccine, called AERAS-422, is a modernized version of the currently used TB vaccine --...

TOPICS:

70 percent of women likely to experience sexual problems after breast cancer

September 22, 2010 11:32 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) A new study published in the Journal of Sexual Medicine looked at whether women were more likely to experience sexual problems after breast cancer. The results showed that 70 percent of women were facing sexual function problems approximately two years post diagnosis.

TOPICS:

Meggitt Sensing Systems debuts Sensorex MEMS

September 22, 2010 7:33 pm | by I-Micronews | News | Comments

Model SX43040 includes triaxial inertial measurement with integral digital compensation.

New launch MEMS gyro - 100th the weight, draws 1/10th the power and is 1/3rd the cost of current MEMS gyros

September 22, 2010 7:33 pm | by I-Micronews | News | Comments

Leading Japanese RC model helicopter equipment manufacturer Futaba® selects Silicon Sensing?s new PinPoint® gyro

Advertisement

Talking while walking puts Parkinson's patients at risk for falls(2)

September 22, 2010 3:39 pm | by EurekAlert | News | Comments

(Florida State University) We've all heard the saying about people who can't walk and chew gum at the same time, but it turns out that walking and talking is difficult enough, especially for people with Parkinson's disease who are at increased risk for falls with injury.

TOPICS:

Talking while walking puts Parkinson's patients at risk for falls

September 22, 2010 3:38 pm | News | Comments

Florida State University

MicroRNA Panel Provides a More Precise Lung Cancer Diagnosis(2)

September 22, 2010 3:32 pm | by AACR | News | Comments

DENVER — A test based on a panel of microRNAs under development by Rosetta Genomics, Ltd., in Rehovot, Israel, may allow for more precise diagnosis and better targeted therapy for patients with lung cancer.

TOPICS:

MicroRNA Panel Provides a More Precise Lung Cancer Diagnosis

September 22, 2010 3:31 pm | News | Comments

DENVER — A test based on a panel of microRNAs under development by Rosetta Genomics, Ltd., in Rehovot, Israel, may allow for more precise diagnosis and better targeted therapy for patients with lung cancer.

Insurers stop selling new child-only health plans

September 22, 2010 1:45 pm | by TOM MURPHY - AP Business Writer - Associated Press | News | Comments

Several health insurers say they will stop selling new child-only individual insurance policies as they face a health care reform provision that will prevent them from excluding children with potentially costly pre-existing conditions.An insurance industry representative said the decision...

Amedisys closes 39 agencies; reduces 2011 plans

September 22, 2010 1:45 pm | by The Associated Press | News | Comments

Home health provider Amedisys Inc. said on Wednesday that it would close 39 locations and open fewer new ones next year.The company said 13 agencies (including nine home health agencies and four for hospice) would close altogether. Director of Investor Relations Kevin B. LeBlanc said those...

Transcatheter Aortic Valve Implantation Shows Promise for Patients Too Sick for Conventional Surgery

September 22, 2010 1:32 pm | by University Of Pennsylvania | News | Comments

Just released data from a clinical trial shows promise for a new minimally invasive treatment option for patients with severe aortic stenosis who are too sick for traditional forms of open-heart surgery. As compared to standard medical therapy, the new procedure, transcatheter aortic...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading